Introduction: Gummy Smile Epidemiology and Aesthetic Impact

A gummy smile, defined as excessive gingival display exceeding 3mm of gingival margin visibility during smile, occurs in approximately 10-30% of the adult population depending on demographic factors and measurement criteria. While excessive gingival display carries no pathological consequences, the aesthetic concern is substantial—patients frequently cite gummy smile as a primary motivation for cosmetic dental treatment, with psychological impact including reduced smile confidence and social anxiety.

The etiology of gummy smile is multifactorial, encompassing dental, skeletal, muscular, and soft tissue components in variable combinations. Therefore, successful treatment requires comprehensive analysis of the individual's gummy smile etiology followed by selection of treatment modality specifically addressing the identified cause. A single universal treatment approach is inappropriate—what resolves a muscular hypermobility gummy smile (botulinum toxin) proves ineffective for skeletal vertical maxillary excess and may cause harm if applied without understanding the underlying etiology.

Gummy Smile Etiology Classification and Clinical Assessment

Altered Passive Eruption (APE)

Altered passive eruption represents the most common etiology, accounting for 40-50% of gummy smile cases. In normal eruption, teeth erupt through bone and gingival tissues until the incisal edges reach the occlusal plane. After occlusal contact, the gingival margin remodels to its final position at approximately 1-2mm apical to the cementoenamel junction (CEJ), exposing the full clinical crown height.

In altered passive eruption, the gingival margin fails to recede after eruption completion, remaining at the incisal edge or leaving excessive clinical crown height unexposed. The gingival sulcus measures abnormally deep (6-8mm), exceeding the normal 1-3mm, reflecting failure of the junctional epithelium to migrate apically to the appropriate level relative to alveolar bone crest.

APE classifies into three subgroups: Type A (excessive gingiva exposure with normal crown length), Type B (short clinical crown from both excessive gingiva and short anatomical crown), and Type C (short clinical crown from normal gingiva position and naturally short crown). Type A requires crown lengthening; Type B requires crown lengthening plus possible veneering; Type C requires veneering or bonding alone.

Clinical diagnosis involves measuring gingival display during smiling (>3mm indicates excess), assessing clinical crown height (normal 10-12mm for incisors), and probing sulcus depth (>3mm suggests APE). Radiographically, altered passive eruption shows alveolar bone crest position close to the CEJ (bone crest-CEJ distance <4mm when normal is 5-6mm), and the gingival margin located coronal to the bone crest level by an excessive distance.

Vertical Maxillary Excess (VME)

Vertical maxillary excess, a skeletal maxillary anterior-posterior vertical dimension problem, accounts for 25-35% of gummy smile cases. In VME, the maxilla displays vertical overdevelopment, resulting in excessive anterior face height and consequently excessive gingival display during smiling. Clinical assessment reveals increased anterior facial height ratio (measurements from nasion to menton compared to cranial base size show disproportionate anterior face height).

Patients with VME typically demonstrate:

  • Increased anterior facial height
  • Open mouth posture at rest
  • Dental characteristics including excessive vertical overbite or anterior open bite
  • Deep palate configuration

VME requires orthognathic surgery (maxillary intrusion with Le Fort I osteotomy) for definitive correction. Non-surgical approaches including botulinum toxin provide cosmetic improvement but do not correct the underlying skeletal problem. Hypermobile Upper Lip

Overactive muscle function of the levator labii superioris, levator labii superioris alaeque nasi, zygomaticus major, or zygomaticus minor muscles create excessive gingival display during smiling despite normal gingival levels and skeletal relationships. This muscular hypermobility accounts for 20-30% of gummy smile cases.

Clinical assessment involves smiling observation—if gingival display increases markedly from rest to smile while skeletal and gingival positions appear normal, muscular hypermobility is likely. Additionally, measurement of lip length at rest compared to active smile position reveals excessive upward lip migration during smiling (>8mm upward movement indicates hypermobility).

Short Upper Lip

Short vertical upper lip length (<18-20mm in females, <20-22mm in males) creates relative gingival excess even with normal gingival position and skeletal relationships. Short upper lip is frequently hereditary, reflecting familial patterns in craniofacial morphology.

Treatment Modality Selection Algorithm

Crown Lengthening for Altered Passive Eruption

Crown lengthening surgically repositions the gingival margin apically, exposing additional clinical crown. The procedure involves gingival flap reflection, bone contouring to establish appropriate biological width (distance from alveolar bone crest to desired gingival margin), and suturing to reposition gingival margin apically.

Critical timing considerations include the biological width maintenance—at least 3mm of distance must remain between the final gingival position and the alveolar bone crest to preserve periodontal health and allow adequate healing. Therefore, the amount of crown lengthening possible is limited by alveolar bone height—if excessive bone loss is required for adequate crown length exposure, the procedure risks creating unesthetic root exposure or compromising tooth stability.

Healing timeline post-crown lengthening extends 3-6 months, during which:

  • Week 1-2: Initial wound healing with suture removal at approximately day 10-14
  • Week 2-4: Gingival margin stabilization, though final position may continue changing slightly
  • Month 2-3: Complete epithelialization and collagen remodeling
  • Month 3-6: Final gingival contour stabilization with aesthetic maturation

Permanent crown or extensive restorations (veneers, bonding) should not be placed until 3-4 months post-surgery to ensure final gingival position stability and appropriate margins. Placing restorations earlier risks subgingival margin placement if gingival margin continues apical migration during healing.

Aesthetic outcomes in appropriate candidates (Type A APE with adequate bone) show excellent results—gingival display reduction of 3-5mm is typical, with patient satisfaction rates >85%.

Lip Repositioning Surgery

Lip repositioning procedures reduce the maximum vertical distance lip travels during smiling, particularly beneficial in hypermobile upper lip etiology. Several approaches exist:

Maxillary labial frenectomy with myectomy (surgical removal of superior labial frenulum fibers and partial muscle resection) limits upward lip migration, reducing gingival display by 2-3mm. The procedure is minimally invasive, performed under local anesthesia, with rapid healing (5-7 days).

Extended lip repositioning involves submucosal dissection of the upper lip with resection of muscle fibers and repositioning of the lip to a lower position. The procedure reduces gingival display by 3-5mm and is particularly suited for short upper lip correction.

Healing timeline post-lip repositioning:

  • Days 1-7: Edema, discomfort managed with mild analgesics
  • Week 1-2: Suture removal, gradual return to normal function
  • Week 2-4: Edema resolution
  • Month 1-3: Final aesthetic result stabilization

The procedure carries some risk of overcorrection (insufficient gingival display, creating unaesthetic low lip line or inability to achieve lip seal at rest), emphasizing the importance of conservative initial approach with possible secondary adjustment if needed. Botulinum Toxin for Muscular Hypermobility

Botulinum toxin injection represents the least invasive approach, with particular efficacy in pure muscular hypermobility gummy smile (normal gingival levels, normal skeleton, but excessive muscle contraction during smiling). Typical dosing involves 2.5 Units per side injected into the levator labii superioris muscle at specific anatomical landmarks, with possible additional injections into zygomaticus major if indicated.

Onset of effect occurs 3-7 days post-injection, with maximum effect at approximately 14 days. Duration of effect ranges 3-4 months, requiring repeat injections for sustained benefit. Patient satisfaction is typically high (80-90%) due to reversibility and lack of permanent alteration.

Timeline of botulinum toxin effect:

  • Days 1-3: Minimal visible change
  • Days 3-7: Progressive gingival display reduction
  • Days 7-14: Maximum effect achieved
  • Week 2-4: Plateau of effect
  • Month 3-4: Effect begins declining
  • Month 4+: Gradual return to baseline appearance, necessitating repeat injection if continued benefit desired

Adverse effects include lip weakness (difficulty controlling oral fluids, speech changes) if injection technique is imperfect, slight smile asymmetry if unilateral effect occurs, and rarely, unintended facial expression changes if diffusion affects adjacent muscles. Orthognathic Surgery for Vertical Maxillary Excess

Surgical correction of VME involves Le Fort I maxillary osteotomy with superior repositioning (intrusion) of the maxilla to reduce anterior facial height and vertical gingival display. The procedure is performed by oral and maxillofacial surgeons under general anesthesia with typical hospitalization of 1-2 days.

Surgical correction is the definitive treatment for skeletal VME, achieving permanent gingival display reduction of 4-8mm depending on surgical movement magnitude. However, the procedure carries significant morbidity and recovery burden.

Timeline post-orthognathic surgery:

  • Weeks 1-2: Significant swelling, edema, discomfort; liquid diet required
  • Weeks 2-4: Progressive swelling reduction, transition to soft diet
  • Weeks 4-8: Substantial functional recovery, edema largely resolved
  • Months 2-3: Return to normal diet and activities
  • Months 3-6: Continued proprioceptive adaptation and facial proprioception normalization
  • Months 6-12: Final skeletal and soft tissue adaptation

Occlusal correction is a concurrent benefit in many patients with VME, as the maxillary repositioning simultaneously corrects open bite or excessive overbite frequently accompanying VME.

Treatment Selection Algorithm

The appropriate treatment modality selection algorithm follows this logic:

1. Measure gingival display, dental proportions, and skeletal relationships 2. Determine etiology: Altered passive eruption (gingival excessive, normal skeleton, normal lip length), vertical maxillary excess (excessive facial height, excessive gingival display at rest), hypermobile upper lip (normal gingival position and skeleton, excessive upward lip movement), or short upper lip (normal everything but lip length) 3. Match treatment:

  • APE Type A → Crown lengthening (definitive, permanent)
  • APE Type B → Crown lengthening plus veneering
  • VME → Orthognathic surgery (definitive) or botulinum toxin (temporary cosmetic)
  • Hypermobile lip → Botulinum toxin (reversible) or lip repositioning (permanent)
  • Short upper lip → Lip repositioning or orthodontic intrusion (rare)

Timeline Summary and Clinical Considerations

Gummy smile treatment timelines vary dramatically by modality. Botulinum toxin provides rapid (14-day) reversible improvement suitable for patients desiring trial of effect or those with multiple treatment options. Crown lengthening provides permanent 3-5mm gingival display reduction with 3-month healing. Orthognathic surgery provides permanent 4-8mm reduction with 6-12 month recovery. The choice of treatment modality should reflect patient preferences regarding permanence, invasiveness, recovery time, and cost alongside clinical assessment of the specific etiology. Comprehensive pre-operative analysis and patient education regarding realistic expectations for the selected treatment modality are essential for achieving high patient satisfaction.